Characterization, Optimization, In Vitro and In Vivo Evaluation of Simvastatin Proliposomes, as a Drug Delivery
- 13 May 2020
- journal article
- research article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 21 (4) , 1-15
Abstract
Simvastatin a cholesterol-lowering agent used to treat hypercholesterolemia, coronary heart disease, and dyslipidemia. However, simvastatin (SV) has shownKeywords
This publication has 48 references indexed in Scilit:
- Inhaled pyrazinamide proliposome for targeting alveolar macrophagesDrug Delivery, 2012
- Development of delayed-release proliposomes tablets for oral protein drug deliveryDrug Development and Industrial Pharmacy, 2011
- Isoniazid Proliposome Powders for Inhalation—Preparation, Characterization and Cell Culture StudiesInternational Journal of Molecular Sciences, 2011
- Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivoActa Pharmacologica Sinica, 2011
- Glyceryl Monooleate/Poloxamer 407 Cubic Nanoparticles as Oral Drug Delivery Systems: I. In Vitro Evaluation and Enhanced Oral Bioavailability of the Poorly Water-Soluble Drug SimvastatinAAPS PharmSciTech, 2009
- Past, Present, and Future Technologies for Oral Delivery of Therapeutic ProteinsJournal of Pharmaceutical Sciences, 2008
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- Encapsulation of calcitonin in liposome's depends on the vesicle preparation methodJournal of Microencapsulation, 1997
- Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tractLife Sciences, 1993
- Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and SimvastatinJournal of Pharmaceutical Sciences, 1991